Cyproterone acetate: new advice to minimise risk of meningioma

Risk of meningioma increases with increasing cumulative dose; use is contraindicated in patients with previous or current meningioma for all indications and should only be considered for severe hypersexuality in adult men when other interventions are inappropriate.


Medicines and Healthcare products Regulatory Agency